nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00081	0.000921	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—lung cancer	0.000809	0.00092	CcSEcCtD
Glycopyrrolate—Fatigue—Gemcitabine—lung cancer	0.000809	0.00092	CcSEcCtD
Glycopyrrolate—Confusional state—Etoposide—lung cancer	0.000808	0.000919	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—lung cancer	0.000804	0.000914	CcSEcCtD
Glycopyrrolate—Constipation—Gemcitabine—lung cancer	0.000802	0.000912	CcSEcCtD
Glycopyrrolate—Pain—Gemcitabine—lung cancer	0.000802	0.000912	CcSEcCtD
Glycopyrrolate—Nausea—Erlotinib—lung cancer	0.000802	0.000912	CcSEcCtD
Glycopyrrolate—Dry mouth—Paclitaxel—lung cancer	0.000801	0.000911	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Etoposide—lung cancer	0.000801	0.000911	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—lung cancer	0.000801	0.000911	CcSEcCtD
Glycopyrrolate—Dysgeusia—Docetaxel—lung cancer	0.000799	0.000908	CcSEcCtD
Glycopyrrolate—Infection—Etoposide—lung cancer	0.000796	0.000905	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Irinotecan—lung cancer	0.000794	0.000902	CcSEcCtD
Glycopyrrolate—Confusional state—Paclitaxel—lung cancer	0.000792	0.000901	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—lung cancer	0.000789	0.000897	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Irinotecan—lung cancer	0.000787	0.000896	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—lung cancer	0.000786	0.000894	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Paclitaxel—lung cancer	0.000785	0.000893	CcSEcCtD
Glycopyrrolate—Oedema—Paclitaxel—lung cancer	0.000785	0.000893	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—lung cancer	0.000784	0.000892	CcSEcCtD
Glycopyrrolate—Tachycardia—Etoposide—lung cancer	0.000782	0.000889	CcSEcCtD
Glycopyrrolate—Infection—Paclitaxel—lung cancer	0.00078	0.000887	CcSEcCtD
Glycopyrrolate—Skin disorder—Etoposide—lung cancer	0.000778	0.000885	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—lung cancer	0.000777	0.000884	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—lung cancer	0.000775	0.000881	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Etoposide—lung cancer	0.000774	0.000881	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Gemcitabine—lung cancer	0.000773	0.000879	CcSEcCtD
Glycopyrrolate—Dizziness—Vinorelbine—lung cancer	0.000772	0.000878	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Paclitaxel—lung cancer	0.00077	0.000876	CcSEcCtD
Glycopyrrolate—Tachycardia—Paclitaxel—lung cancer	0.000767	0.000872	CcSEcCtD
Glycopyrrolate—Skin disorder—Paclitaxel—lung cancer	0.000763	0.000868	CcSEcCtD
Glycopyrrolate—Abdominal pain—Irinotecan—lung cancer	0.000761	0.000866	CcSEcCtD
Glycopyrrolate—Body temperature increased—Irinotecan—lung cancer	0.000761	0.000866	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Paclitaxel—lung cancer	0.000759	0.000863	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—lung cancer	0.000757	0.00086	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—lung cancer	0.000756	0.00086	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Cisplatin—lung cancer	0.000755	0.000858	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—lung cancer	0.000752	0.000856	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—lung cancer	0.000752	0.000856	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—lung cancer	0.000752	0.000856	CcSEcCtD
Glycopyrrolate—Hypotension—Etoposide—lung cancer	0.000748	0.000851	CcSEcCtD
Glycopyrrolate—Pain—Cisplatin—lung cancer	0.000748	0.00085	CcSEcCtD
Glycopyrrolate—Vomiting—Vinorelbine—lung cancer	0.000742	0.000844	CcSEcCtD
Glycopyrrolate—Body temperature increased—Gemcitabine—lung cancer	0.000742	0.000843	CcSEcCtD
Glycopyrrolate—Rash—Vinorelbine—lung cancer	0.000736	0.000837	CcSEcCtD
Glycopyrrolate—Dermatitis—Vinorelbine—lung cancer	0.000736	0.000836	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—lung cancer	0.000735	0.000836	CcSEcCtD
Glycopyrrolate—Hypotension—Paclitaxel—lung cancer	0.000734	0.000835	CcSEcCtD
Glycopyrrolate—Headache—Vinorelbine—lung cancer	0.000731	0.000832	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—lung cancer	0.000721	0.00082	CcSEcCtD
Glycopyrrolate—Palpitations—Docetaxel—lung cancer	0.000721	0.00082	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Cisplatin—lung cancer	0.000721	0.000819	CcSEcCtD
Glycopyrrolate—Somnolence—Etoposide—lung cancer	0.000712	0.00081	CcSEcCtD
Glycopyrrolate—Insomnia—Paclitaxel—lung cancer	0.00071	0.000808	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—lung cancer	0.00071	0.000807	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Irinotecan—lung cancer	0.00071	0.000807	CcSEcCtD
Glycopyrrolate—Convulsion—Docetaxel—lung cancer	0.000707	0.000804	CcSEcCtD
Glycopyrrolate—Hypertension—Docetaxel—lung cancer	0.000704	0.000801	CcSEcCtD
Glycopyrrolate—Somnolence—Paclitaxel—lung cancer	0.000698	0.000794	CcSEcCtD
Glycopyrrolate—Nausea—Vinorelbine—lung cancer	0.000694	0.000789	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Etoposide—lung cancer	0.000692	0.000786	CcSEcCtD
Glycopyrrolate—Dyspepsia—Paclitaxel—lung cancer	0.000691	0.000786	CcSEcCtD
Glycopyrrolate—Body temperature increased—Cisplatin—lung cancer	0.000691	0.000786	CcSEcCtD
Glycopyrrolate—Asthenia—Irinotecan—lung cancer	0.000691	0.000786	CcSEcCtD
Glycopyrrolate—Fatigue—Etoposide—lung cancer	0.000691	0.000785	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00069	0.000784	CcSEcCtD
Glycopyrrolate—Pain—Etoposide—lung cancer	0.000685	0.000779	CcSEcCtD
Glycopyrrolate—Constipation—Etoposide—lung cancer	0.000685	0.000779	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—lung cancer	0.000683	0.000777	CcSEcCtD
Glycopyrrolate—Dry mouth—Docetaxel—lung cancer	0.000679	0.000772	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000679	0.000772	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000678	0.000771	CcSEcCtD
Glycopyrrolate—Fatigue—Paclitaxel—lung cancer	0.000677	0.00077	CcSEcCtD
Glycopyrrolate—Asthenia—Gemcitabine—lung cancer	0.000673	0.000765	CcSEcCtD
Glycopyrrolate—Constipation—Paclitaxel—lung cancer	0.000672	0.000764	CcSEcCtD
Glycopyrrolate—Pain—Paclitaxel—lung cancer	0.000672	0.000764	CcSEcCtD
Glycopyrrolate—Confusional state—Docetaxel—lung cancer	0.000671	0.000763	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—lung cancer	0.000667	0.000758	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Docetaxel—lung cancer	0.000666	0.000757	CcSEcCtD
Glycopyrrolate—Oedema—Docetaxel—lung cancer	0.000666	0.000757	CcSEcCtD
Glycopyrrolate—Pruritus—Gemcitabine—lung cancer	0.000664	0.000755	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—lung cancer	0.000662	0.000753	CcSEcCtD
Glycopyrrolate—Infection—Docetaxel—lung cancer	0.000661	0.000752	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Etoposide—lung cancer	0.00066	0.000751	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—lung cancer	0.000659	0.000749	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—lung cancer	0.000655	0.000745	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Etoposide—lung cancer	0.000655	0.000745	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Docetaxel—lung cancer	0.000653	0.000742	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—lung cancer	0.000651	0.000741	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—lung cancer	0.000651	0.000741	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—lung cancer	0.000651	0.000741	CcSEcCtD
Glycopyrrolate—Tachycardia—Docetaxel—lung cancer	0.00065	0.000739	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Paclitaxel—lung cancer	0.000647	0.000736	CcSEcCtD
Glycopyrrolate—Skin disorder—Docetaxel—lung cancer	0.000647	0.000735	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Cisplatin—lung cancer	0.000644	0.000733	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000642	0.00073	CcSEcCtD
Glycopyrrolate—Dizziness—Irinotecan—lung cancer	0.000637	0.000724	CcSEcCtD
Glycopyrrolate—Urticaria—Etoposide—lung cancer	0.000636	0.000724	CcSEcCtD
Glycopyrrolate—Abdominal pain—Etoposide—lung cancer	0.000633	0.00072	CcSEcCtD
Glycopyrrolate—Body temperature increased—Etoposide—lung cancer	0.000633	0.00072	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—lung cancer	0.000633	0.00072	CcSEcCtD
Glycopyrrolate—Asthenia—Cisplatin—lung cancer	0.000627	0.000713	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—lung cancer	0.000627	0.000713	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—lung cancer	0.000625	0.00071	CcSEcCtD
Glycopyrrolate—Urticaria—Paclitaxel—lung cancer	0.000624	0.00071	CcSEcCtD
Glycopyrrolate—Hypotension—Docetaxel—lung cancer	0.000622	0.000707	CcSEcCtD
Glycopyrrolate—Abdominal pain—Paclitaxel—lung cancer	0.000621	0.000706	CcSEcCtD
Glycopyrrolate—Body temperature increased—Paclitaxel—lung cancer	0.000621	0.000706	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—lung cancer	0.000614	0.000699	CcSEcCtD
Glycopyrrolate—Vomiting—Irinotecan—lung cancer	0.000612	0.000696	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—lung cancer	0.000611	0.000695	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—lung cancer	0.000609	0.000692	CcSEcCtD
Glycopyrrolate—Rash—Irinotecan—lung cancer	0.000607	0.000691	CcSEcCtD
Glycopyrrolate—Dermatitis—Irinotecan—lung cancer	0.000607	0.00069	CcSEcCtD
Glycopyrrolate—Headache—Irinotecan—lung cancer	0.000603	0.000686	CcSEcCtD
Glycopyrrolate—Insomnia—Docetaxel—lung cancer	0.000602	0.000685	CcSEcCtD
Glycopyrrolate—Vomiting—Gemcitabine—lung cancer	0.000596	0.000678	CcSEcCtD
Glycopyrrolate—Somnolence—Docetaxel—lung cancer	0.000592	0.000673	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—lung cancer	0.000592	0.000673	CcSEcCtD
Glycopyrrolate—Rash—Gemcitabine—lung cancer	0.000591	0.000673	CcSEcCtD
Glycopyrrolate—Dermatitis—Gemcitabine—lung cancer	0.000591	0.000672	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Etoposide—lung cancer	0.00059	0.000671	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—lung cancer	0.000588	0.000669	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—lung cancer	0.000588	0.000669	CcSEcCtD
Glycopyrrolate—Headache—Gemcitabine—lung cancer	0.000588	0.000668	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—lung cancer	0.000586	0.000667	CcSEcCtD
Glycopyrrolate—Dyspepsia—Docetaxel—lung cancer	0.000586	0.000666	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—lung cancer	0.000582	0.000662	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Paclitaxel—lung cancer	0.000579	0.000658	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—lung cancer	0.000578	0.000657	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—lung cancer	0.000576	0.000655	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Docetaxel—lung cancer	0.000575	0.000654	CcSEcCtD
Glycopyrrolate—Asthenia—Etoposide—lung cancer	0.000575	0.000654	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—lung cancer	0.000575	0.000654	CcSEcCtD
Glycopyrrolate—Fatigue—Docetaxel—lung cancer	0.000574	0.000653	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—lung cancer	0.000573	0.000652	CcSEcCtD
Glycopyrrolate—Nausea—Irinotecan—lung cancer	0.000572	0.000651	CcSEcCtD
Glycopyrrolate—Constipation—Docetaxel—lung cancer	0.000569	0.000647	CcSEcCtD
Glycopyrrolate—Pain—Docetaxel—lung cancer	0.000569	0.000647	CcSEcCtD
Glycopyrrolate—Pruritus—Etoposide—lung cancer	0.000567	0.000644	CcSEcCtD
Glycopyrrolate—Asthenia—Paclitaxel—lung cancer	0.000563	0.000641	CcSEcCtD
Glycopyrrolate—Nausea—Gemcitabine—lung cancer	0.000557	0.000634	CcSEcCtD
Glycopyrrolate—Vomiting—Cisplatin—lung cancer	0.000556	0.000632	CcSEcCtD
Glycopyrrolate—Pruritus—Paclitaxel—lung cancer	0.000556	0.000632	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—lung cancer	0.000554	0.00063	CcSEcCtD
Glycopyrrolate—Rash—Cisplatin—lung cancer	0.000551	0.000627	CcSEcCtD
Glycopyrrolate—Dermatitis—Cisplatin—lung cancer	0.000551	0.000626	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Docetaxel—lung cancer	0.000549	0.000624	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Docetaxel—lung cancer	0.000544	0.000619	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—lung cancer	0.000543	0.000617	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—lung cancer	0.000543	0.000617	CcSEcCtD
Glycopyrrolate—Dizziness—Etoposide—lung cancer	0.00053	0.000602	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—lung cancer	0.000527	0.000599	CcSEcCtD
Glycopyrrolate—Body temperature increased—Docetaxel—lung cancer	0.000526	0.000598	CcSEcCtD
Glycopyrrolate—Abdominal pain—Docetaxel—lung cancer	0.000526	0.000598	CcSEcCtD
Glycopyrrolate—Dizziness—Paclitaxel—lung cancer	0.000519	0.000591	CcSEcCtD
Glycopyrrolate—Nausea—Cisplatin—lung cancer	0.000519	0.000591	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—lung cancer	0.000512	0.000583	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—lung cancer	0.000509	0.000579	CcSEcCtD
Glycopyrrolate—Vomiting—Etoposide—lung cancer	0.000509	0.000579	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—lung cancer	0.000509	0.000579	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—lung cancer	0.000509	0.000579	CcSEcCtD
Glycopyrrolate—Rash—Etoposide—lung cancer	0.000505	0.000574	CcSEcCtD
Glycopyrrolate—Dermatitis—Etoposide—lung cancer	0.000505	0.000574	CcSEcCtD
Glycopyrrolate—Headache—Etoposide—lung cancer	0.000502	0.000571	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—lung cancer	0.000502	0.00057	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—lung cancer	0.0005	0.000568	CcSEcCtD
Glycopyrrolate—Vomiting—Paclitaxel—lung cancer	0.000499	0.000568	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—lung cancer	0.000499	0.000567	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000497	0.000565	CcSEcCtD
Glycopyrrolate—Rash—Paclitaxel—lung cancer	0.000495	0.000563	CcSEcCtD
Glycopyrrolate—Dermatitis—Paclitaxel—lung cancer	0.000495	0.000563	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—lung cancer	0.000494	0.000562	CcSEcCtD
Glycopyrrolate—Headache—Paclitaxel—lung cancer	0.000492	0.00056	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Docetaxel—lung cancer	0.00049	0.000558	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—lung cancer	0.000484	0.00055	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—lung cancer	0.00048	0.000546	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—lung cancer	0.00048	0.000546	CcSEcCtD
Glycopyrrolate—Asthenia—Docetaxel—lung cancer	0.000478	0.000543	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—lung cancer	0.000477	0.000542	CcSEcCtD
Glycopyrrolate—Nausea—Etoposide—lung cancer	0.000476	0.000541	CcSEcCtD
Glycopyrrolate—Pruritus—Docetaxel—lung cancer	0.000471	0.000536	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—lung cancer	0.000471	0.000535	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—lung cancer	0.000468	0.000532	CcSEcCtD
Glycopyrrolate—Nausea—Paclitaxel—lung cancer	0.000467	0.000531	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—lung cancer	0.000466	0.00053	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—lung cancer	0.000464	0.000527	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—lung cancer	0.00045	0.000512	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—lung cancer	0.000448	0.00051	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—lung cancer	0.000441	0.000502	CcSEcCtD
Glycopyrrolate—Dizziness—Docetaxel—lung cancer	0.00044	0.000501	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—lung cancer	0.00044	0.0005	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—lung cancer	0.000434	0.000494	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00043	0.000489	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—lung cancer	0.000427	0.000485	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—lung cancer	0.000424	0.000482	CcSEcCtD
Glycopyrrolate—Vomiting—Docetaxel—lung cancer	0.000423	0.000481	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—lung cancer	0.000422	0.00048	CcSEcCtD
Glycopyrrolate—Rash—Docetaxel—lung cancer	0.00042	0.000477	CcSEcCtD
Glycopyrrolate—Dermatitis—Docetaxel—lung cancer	0.000419	0.000477	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—lung cancer	0.000419	0.000476	CcSEcCtD
Glycopyrrolate—Headache—Docetaxel—lung cancer	0.000417	0.000474	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—lung cancer	0.000415	0.000472	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—lung cancer	0.000415	0.000472	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000414	0.000471	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—lung cancer	0.000414	0.00047	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—lung cancer	0.000413	0.000469	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—lung cancer	0.00041	0.000467	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—lung cancer	0.000407	0.000463	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—lung cancer	0.000405	0.000461	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—lung cancer	0.000404	0.000459	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—lung cancer	0.000402	0.000457	CcSEcCtD
Glycopyrrolate—Nausea—Docetaxel—lung cancer	0.000395	0.00045	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—lung cancer	0.000395	0.00045	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—lung cancer	0.000392	0.000446	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—lung cancer	0.000388	0.000441	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—lung cancer	0.000381	0.000433	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—lung cancer	0.000379	0.000431	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—lung cancer	0.000379	0.000431	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—lung cancer	0.000376	0.000427	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—lung cancer	0.000369	0.00042	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—lung cancer	0.000366	0.000416	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000359	0.000408	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—lung cancer	0.000358	0.000407	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—lung cancer	0.000355	0.000404	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—lung cancer	0.000355	0.000404	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—lung cancer	0.000353	0.000402	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—lung cancer	0.000344	0.000391	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—lung cancer	0.000342	0.000389	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—lung cancer	0.00034	0.000386	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—lung cancer	0.000339	0.000386	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—lung cancer	0.00033	0.000375	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—lung cancer	0.000328	0.000373	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—lung cancer	0.000328	0.000373	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—lung cancer	0.000317	0.000361	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—lung cancer	0.000306	0.000348	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—lung cancer	0.000305	0.000347	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—lung cancer	0.000303	0.000344	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—lung cancer	0.000302	0.000344	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—lung cancer	0.000301	0.000342	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—lung cancer	0.000298	0.000339	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—lung cancer	0.000294	0.000334	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—lung cancer	0.000285	0.000324	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—lung cancer	0.000275	0.000312	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—lung cancer	0.000264	0.0003	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—lung cancer	0.000262	0.000298	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—lung cancer	0.000262	0.000298	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—lung cancer	0.00026	0.000296	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—lung cancer	0.000247	0.000281	CcSEcCtD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2—lung cancer	3.28e-05	0.000272	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—lung cancer	3.28e-05	0.000272	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	3.28e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PIK3CA—lung cancer	3.27e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	3.24e-05	0.000269	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—KRAS—lung cancer	3.23e-05	0.000268	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAP2K1—lung cancer	3.18e-05	0.000264	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CD—lung cancer	3.16e-05	0.000262	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—lung cancer	3.16e-05	0.000262	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—lung cancer	3.15e-05	0.000261	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ERBB3—lung cancer	3.14e-05	0.00026	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PIK3CA—lung cancer	3.13e-05	0.00026	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ERBB3—lung cancer	3.13e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—lung cancer	3.12e-05	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ERBB3—lung cancer	3.1e-05	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—KRAS—lung cancer	3.1e-05	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CG—lung cancer	3.02e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2—lung cancer	3.02e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2—lung cancer	3.01e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TERT—lung cancer	3.01e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TERT—lung cancer	3e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2—lung cancer	2.98e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PIK3CA—lung cancer	2.97e-05	0.000246	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TERT—lung cancer	2.97e-05	0.000246	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MDM2—lung cancer	2.96e-05	0.000245	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RAF1—lung cancer	2.95e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGFR1—lung cancer	2.92e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ERBB2—lung cancer	2.92e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGFR1—lung cancer	2.91e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGFR1—lung cancer	2.88e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MTOR—lung cancer	2.88e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CB—lung cancer	2.88e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIF1A—lung cancer	2.88e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—POMC—lung cancer	2.87e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIF1A—lung cancer	2.87e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CA—lung cancer	2.85e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIF1A—lung cancer	2.84e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MDM2—lung cancer	2.83e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RAF1—lung cancer	2.82e-05	0.000234	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CREBBP—lung cancer	2.8e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ERBB2—lung cancer	2.79e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOA1—lung cancer	2.78e-05	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—lung cancer	2.77e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOA1—lung cancer	2.77e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MTOR—lung cancer	2.76e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CB—lung cancer	2.76e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KDR—lung cancer	2.75e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—HRAS—lung cancer	2.75e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KDR—lung cancer	2.74e-05	0.000227	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOA1—lung cancer	2.74e-05	0.000227	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KDR—lung cancer	2.71e-05	0.000225	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—lung cancer	2.67e-05	0.000222	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CD—lung cancer	2.66e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—lung cancer	2.65e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—lung cancer	2.65e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2—lung cancer	2.64e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—HRAS—lung cancer	2.63e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—lung cancer	2.63e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—lung cancer	2.62e-05	0.000217	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCND1—lung cancer	2.58e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—JUN—lung cancer	2.57e-05	0.000213	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—lung cancer	2.56e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—lung cancer	2.54e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KIT—lung cancer	2.53e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CG—lung cancer	2.53e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APC—lung cancer	2.53e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—NRAS—lung cancer	2.53e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2—lung cancer	2.53e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CG—lung cancer	2.53e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KIT—lung cancer	2.53e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APC—lung cancer	2.53e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—NRAS—lung cancer	2.53e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—lung cancer	2.52e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGF—lung cancer	2.5e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—lung cancer	2.5e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.5e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APC—lung cancer	2.5e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KIT—lung cancer	2.5e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.5e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGF—lung cancer	2.5e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1A—lung cancer	2.49e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTEN—lung cancer	2.49e-05	0.000206	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGF—lung cancer	2.47e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCND1—lung cancer	2.47e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—JUN—lung cancer	2.46e-05	0.000204	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—lung cancer	2.43e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MAPK3—lung cancer	2.43e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MAPK3—lung cancer	2.42e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—POMC—lung cancer	2.41e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—POMC—lung cancer	2.4e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—lung cancer	2.4e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2.4e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1A—lung cancer	2.39e-05	0.000198	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTEN—lung cancer	2.38e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BRAF—lung cancer	2.38e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—POMC—lung cancer	2.38e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BRAF—lung cancer	2.37e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EP300—lung cancer	2.37e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6R—lung cancer	2.35e-05	0.000195	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BRAF—lung cancer	2.35e-05	0.000195	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CREBBP—lung cancer	2.35e-05	0.000195	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6R—lung cancer	2.35e-05	0.000194	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CREBBP—lung cancer	2.34e-05	0.000194	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—lung cancer	2.32e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6R—lung cancer	2.32e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CREBBP—lung cancer	2.32e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CB—lung cancer	2.31e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—lung cancer	2.31e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SRC—lung cancer	2.31e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—lung cancer	2.3e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—lung cancer	2.29e-05	0.00019	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—lung cancer	2.28e-05	0.000189	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EP300—lung cancer	2.27e-05	0.000188	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—lung cancer	2.25e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAP2K1—lung cancer	2.24e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAP2K1—lung cancer	2.23e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CD—lung cancer	2.23e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—lung cancer	2.23e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CD—lung cancer	2.22e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NRAS—lung cancer	2.22e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAP2K1—lung cancer	2.21e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SRC—lung cancer	2.21e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	2.21e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	2.2e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CD—lung cancer	2.2e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—KRAS—lung cancer	2.18e-05	0.000181	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	2.18e-05	0.00018	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—KRAS—lung cancer	2.17e-05	0.00018	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—KRAS—lung cancer	2.15e-05	0.000178	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—lung cancer	2.15e-05	0.000178	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—lung cancer	2.13e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK3—lung cancer	2.13e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NRAS—lung cancer	2.13e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—lung cancer	2.07e-05	0.000171	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK3—lung cancer	2.04e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—lung cancer	2.02e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	2e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTEN—lung cancer	2e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	2e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MDM2—lung cancer	2e-05	0.000165	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MDM2—lung cancer	1.99e-05	0.000165	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RAF1—lung cancer	1.99e-05	0.000165	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RAF1—lung cancer	1.98e-05	0.000164	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—lung cancer	1.98e-05	0.000164	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.98e-05	0.000164	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MDM2—lung cancer	1.97e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.97e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RAF1—lung cancer	1.96e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ERBB2—lung cancer	1.96e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.94e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—lung cancer	1.94e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.00016	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.00016	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MTOR—lung cancer	1.92e-05	0.000159	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.92e-05	0.000159	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KRAS—lung cancer	1.91e-05	0.000158	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—EP300—lung cancer	1.91e-05	0.000158	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—lung cancer	1.87e-05	0.000155	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—lung cancer	1.86e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HRAS—lung cancer	1.85e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HRAS—lung cancer	1.85e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.84e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.83e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KRAS—lung cancer	1.83e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—lung cancer	1.79e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2—lung cancer	1.78e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—lung cancer	1.78e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.78e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2—lung cancer	1.78e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—lung cancer	1.77e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—lung cancer	1.77e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—lung cancer	1.76e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2—lung cancer	1.76e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CA—lung cancer	1.76e-05	0.000145	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—lung cancer	1.75e-05	0.000145	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCND1—lung cancer	1.74e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JUN—lung cancer	1.73e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCND1—lung cancer	1.73e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JUN—lung cancer	1.73e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCND1—lung cancer	1.72e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JUN—lung cancer	1.71e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—lung cancer	1.7e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—lung cancer	1.69e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—lung cancer	1.68e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CA—lung cancer	1.68e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTEN—lung cancer	1.68e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTEN—lung cancer	1.67e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—lung cancer	1.67e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.66e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTEN—lung cancer	1.66e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.64e-05	0.000136	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.63e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—lung cancer	1.63e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HRAS—lung cancer	1.62e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.62e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EP300—lung cancer	1.6e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EP300—lung cancer	1.59e-05	0.000132	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EP300—lung cancer	1.58e-05	0.000131	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SRC—lung cancer	1.56e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HRAS—lung cancer	1.56e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—lung cancer	1.55e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SRC—lung cancer	1.55e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SRC—lung cancer	1.54e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.52e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.51e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NRAS—lung cancer	1.5e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.5e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NRAS—lung cancer	1.49e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—lung cancer	1.49e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—lung cancer	1.48e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NRAS—lung cancer	1.48e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—lung cancer	1.43e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.41e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CA—lung cancer	1.41e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—lung cancer	1.39e-05	0.000116	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—lung cancer	1.39e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—lung cancer	1.38e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—lung cancer	1.37e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—lung cancer	1.35e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KRAS—lung cancer	1.29e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KRAS—lung cancer	1.28e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KRAS—lung cancer	1.27e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	9.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	9.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.17e-05	9.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—lung cancer	1.15e-05	9.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—lung cancer	1.14e-05	9.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—lung cancer	1.14e-05	9.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—lung cancer	1.13e-05	9.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HRAS—lung cancer	1.09e-05	9.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HRAS—lung cancer	1.09e-05	9.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HRAS—lung cancer	1.08e-05	8.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—lung cancer	1.05e-05	8.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—lung cancer	1.04e-05	8.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—lung cancer	1.03e-05	8.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—lung cancer	9.67e-06	8.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—lung cancer	9.64e-06	7.99e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—lung cancer	9.54e-06	7.91e-05	CbGpPWpGaD
